MPO and metabolic syndrome: In this sense, the findings of this study suggest the protective effect of the LRE on a dyslipidemia model evidenced by the decrease in plasma levels of triglyceride and malondialdehyde, as well as the reduction of plasma myeloperoxidase activity and liver steatosis.